CRB Inverbío SGEIC is thrilled to welcome Prosoma as the newest addition to its portfolio. The firm has recently participated in Prosoma’s Series A funding round, joining Verge and Impact Ventures to support the company’s growth and expansion into the U.S. market.
Prosoma is a global, interdisciplinary team of world-class scientists, psychologists, and engineers, as well as experienced and passionate new-tech entrepreneurs. The team was brought together to deliver digital healthcare solutions at the forefront of innovation in oncology.
Constantly searching for new solutions, their mission is to improve existing mental health care in the field by bridging gaps and addressing emerging challenges and needs of stakeholders throughout the system.
They believe that the future of cancer-related mental health care is digital, scalable, and patient-centered. The potential impact of their solutions enables them not only to enhance patients’ quality of life but also to reduce healthcare costs and economic burdens, thereby contributing to the overall resilience of healthcare systems.
Globally, more than 18 million new cancer cases are diagnosed each year, with over 50% of patients experiencing anxiety, depression, or even post-traumatic stress disorder (PTSD). However, access to personalized psychological support remains limited. Prosoma’s Living Well platform addresses this critical need and is already reimbursed through over 30 selective insurance contracts in Germany and Switzerland. The solution is also undergoing early commercial pilots in the United States.
cloud technology axon
Kintai provides working capital financing to companies with annual rev...
